Join to View Full Profile
945 N 5th StAlbemarle, NC 28001
Phone+1 980-323-7790
Fax+1 704-403-4379
Dr. Schwartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1997 - 2000
Madigan Army Medical CenterResidency, Internal Medicine, 1994 - 1997
Albany Medical CollegeClass of 1994
Certifications & Licensure
NC State Medical License 2005 - 2026
TX State Medical License 2000 - 2005
PA State Medical License 1996 - 2000
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Modular EHR, Cerner Corporation, 2013
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2002 Dec 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- A Study of Regorafenib in Advanced Pancreatic Cancer Patients Start of enrollment: 2014 Jun 06
Publications & Presentations
PubMed
- 11 citationsA case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.Marc Zumberg, Jed B. Gorlin, Elizabeth A. Griffiths, Garry Schwartz, Bradley S. Fletcher
Transfusion. 2020-05-01 - 21 citationsUse of the blood substitute HBOC‐201 in critically ill patients during sickle crisis: a three‐case seriesJonathan M. Davis, Nura El-Haj, Nimish Shah, Garry Schwartz, Margaret Block
Transfusion. 2018-01-01 - 40 citationsTamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing ToxicityDaniel L. Hertz, Allison M. Deal, Joseph G. Ibrahim, Christine M. Walko, Karen E. Weck
The Oncologist. 2016-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
